FDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming data

May 1, 2026 01:33 PM EDT PharmaFDA+ FDA ap­proves Pfiz­er and Arv­inas' breast can­cer drug de­spite un­der­whelm­ing da­ta Max Gelman Senior Editor The FDA on Fri­day ap­proved Pfiz­er and Arv­inas’ drug vepdeges­trant for pa­tients with a cer­tain form of breast can­cer. But it’s … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER